Aditxt, Inc. Proceeds from Loans
Aditxt, Inc. (ADTX) reported Proceeds from Loans of $2.00 million for the 1-month period ending 2023-05-30, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLoans · last filed 2024-04-16
- 2023-05-30: Proceeds from Loans 1 month $2.00M.
- 2023-04-20: Proceeds from Loans 1 month $1.60M.
| Period end | Proceeds from Loans 1 month |
|---|---|
| 2023-05-30 | $2.00M 10-K · filed 2024-04-16 |
| 2023-04-20 | $1.60M 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |